private:amakem
|
883155
|
May 22nd, 2019 12:00AM
|
Amakem NV
|
305
|
3.00
|
Open
|
Pharmaceuticals
|
May 21st, 2019 11:07PM
|
May 21st, 2019 11:07PM
|
Amakem is biopharmaceutical company focusing on kinase inhibitors for treatments for Bowel (IBD, Crohn, Colitis), Eye (DR, DME, AMD) and Lung (PAH, IPF, COPD and asthma) diseases.
Amakem's product pipeline is based on its unique 'Localized Drug Action' platform which generates novel kinase (Rock and LIM) inhibitors.
|
Open
|
biotechnology, kinase inhibitors, medicinal chemistry, opthalmology, Lung diseases, Inflammatory bowel disease
|
Open
|
BioVille, Agoralaan bldg. A bis
|
Diepenbeek
|
Limburg
|
BE
|
3590
|
|
Amakem
|
|
Pharmaceuticals & Biotechnology
|
private:amakem
|
883155
|
Mar 23rd, 2018 12:00AM
|
Amakem NV
|
283
|
4.00
|
Open
|
Pharmaceuticals
|
Mar 23rd, 2017 10:51AM
|
Mar 23rd, 2017 10:51AM
|
Amakem is biopharmaceutical company focusing on kinase inhibitors for treatments for Bowel (IBD, Crohn, Colitis), Eye (DR, DME, AMD) and Lung (PAH, IPF, COPD and asthma) diseases.
Amakem's product pipeline is based on its unique 'Localized Drug Action' platform which generates novel kinase (Rock and LIM) inhibitors.
|
|
|
|
|
|
|
|
|
|
Amakem
|
|
Pharmaceuticals & Biotechnology
|
private:amakem
|
883155
|
Feb 17th, 2018 12:00AM
|
Amakem NV
|
283
|
4.00
|
Open
|
Pharmaceuticals
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
Amakem is biopharmaceutical company focusing on kinase inhibitors for treatments for Bowel (IBD, Crohn, Colitis), Eye (DR, DME, AMD) and Lung (PAH, IPF, COPD and asthma) diseases.
Amakem's product pipeline is based on its unique 'Localized Drug Action' platform which generates novel kinase (Rock and LIM) inhibitors.
|
|
|
|
|
|
|
|
|
|
Amakem
|
|
Pharmaceuticals & Biotechnology
|
private:amakem
|
883155
|
Feb 16th, 2018 12:00AM
|
Amakem NV
|
283
|
4.00
|
Open
|
Pharmaceuticals
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
Amakem is biopharmaceutical company focusing on kinase inhibitors for treatments for Bowel (IBD, Crohn, Colitis), Eye (DR, DME, AMD) and Lung (PAH, IPF, COPD and asthma) diseases.
Amakem's product pipeline is based on its unique 'Localized Drug Action' platform which generates novel kinase (Rock and LIM) inhibitors.
|
|
|
|
|
|
|
|
|
|
Amakem
|
|
Pharmaceuticals & Biotechnology
|
private:amakem
|
883155
|
Feb 15th, 2018 12:00AM
|
Amakem NV
|
283
|
4.00
|
Open
|
Pharmaceuticals
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
Amakem is biopharmaceutical company focusing on kinase inhibitors for treatments for Bowel (IBD, Crohn, Colitis), Eye (DR, DME, AMD) and Lung (PAH, IPF, COPD and asthma) diseases.
Amakem's product pipeline is based on its unique 'Localized Drug Action' platform which generates novel kinase (Rock and LIM) inhibitors.
|
|
|
|
|
|
|
|
|
|
Amakem
|
|
Pharmaceuticals & Biotechnology
|
private:amakem
|
883155
|
Feb 14th, 2018 12:00AM
|
Amakem NV
|
283
|
4.00
|
Open
|
Pharmaceuticals
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
Amakem is biopharmaceutical company focusing on kinase inhibitors for treatments for Bowel (IBD, Crohn, Colitis), Eye (DR, DME, AMD) and Lung (PAH, IPF, COPD and asthma) diseases.
Amakem's product pipeline is based on its unique 'Localized Drug Action' platform which generates novel kinase (Rock and LIM) inhibitors.
|
|
|
|
|
|
|
|
|
|
Amakem
|
|
Pharmaceuticals & Biotechnology
|
private:amakem
|
883155
|
Feb 13th, 2018 12:00AM
|
Amakem NV
|
283
|
4.00
|
Open
|
Pharmaceuticals
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
Amakem is biopharmaceutical company focusing on kinase inhibitors for treatments for Bowel (IBD, Crohn, Colitis), Eye (DR, DME, AMD) and Lung (PAH, IPF, COPD and asthma) diseases.
Amakem's product pipeline is based on its unique 'Localized Drug Action' platform which generates novel kinase (Rock and LIM) inhibitors.
|
|
|
|
|
|
|
|
|
|
Amakem
|
|
Pharmaceuticals & Biotechnology
|
private:amakem
|
883155
|
Feb 12th, 2018 12:00AM
|
Amakem NV
|
283
|
4.00
|
Open
|
Pharmaceuticals
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
Amakem is biopharmaceutical company focusing on kinase inhibitors for treatments for Bowel (IBD, Crohn, Colitis), Eye (DR, DME, AMD) and Lung (PAH, IPF, COPD and asthma) diseases.
Amakem's product pipeline is based on its unique 'Localized Drug Action' platform which generates novel kinase (Rock and LIM) inhibitors.
|
|
|
|
|
|
|
|
|
|
Amakem
|
|
Pharmaceuticals & Biotechnology
|
private:amakem
|
883155
|
Feb 11th, 2018 12:00AM
|
Amakem NV
|
283
|
4.00
|
Open
|
Pharmaceuticals
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
Amakem is biopharmaceutical company focusing on kinase inhibitors for treatments for Bowel (IBD, Crohn, Colitis), Eye (DR, DME, AMD) and Lung (PAH, IPF, COPD and asthma) diseases.
Amakem's product pipeline is based on its unique 'Localized Drug Action' platform which generates novel kinase (Rock and LIM) inhibitors.
|
|
|
|
|
|
|
|
|
|
Amakem
|
|
Pharmaceuticals & Biotechnology
|
private:amakem
|
883155
|
Feb 10th, 2018 12:00AM
|
Amakem NV
|
283
|
4.00
|
Open
|
Pharmaceuticals
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
Amakem is biopharmaceutical company focusing on kinase inhibitors for treatments for Bowel (IBD, Crohn, Colitis), Eye (DR, DME, AMD) and Lung (PAH, IPF, COPD and asthma) diseases.
Amakem's product pipeline is based on its unique 'Localized Drug Action' platform which generates novel kinase (Rock and LIM) inhibitors.
|
|
|
|
|
|
|
|
|
|
Amakem
|
|
Pharmaceuticals & Biotechnology
|